Glenmark Pharmaceuticals has received USFDA approval for Clobetasol Propionate Ointment used for treatment of various skin conditions.
The approved product is a generic version of Fougera Pharmaceuticals Inc’s Temovate Ointment, 0.05 per cent. Glenmark’s current portfolio consists of 113 products authorised for distribution in the US marketplace and approximately 64 ANDA’s pending approval with the USFDA.
Company Profile : Glenmark Pharma Ltd
Leave a Reply